$1.8 Million Awarded To Fund Cutting-Edge Arthritis Research

$1.8 Million Awarded To Fund Cutting-Edge Arthritis Research

Arthritis National Research Foundation (ANRF) is honored to announce it has awarded $1.8 million in arthritis research grants. The amount represents the largest commitment to arthritis research to date ensuring that ANRF maintains it’s mission of funding research to cure arthritis. ANRF continues to fund innovative research grants to find new treatments and cures for arthritis and related autoimmune diseases.

2019-20 ANRF Scholars

Investing in Extraordinary Talent


ANRF Scholars represent the crème de la crème of a highly competitive field of newer MD, PhD and MD, PhD scientists at nonprofit research institutions across the United States. All arthritis research grant applications are reviewed annually by world-renowned physician-scientists on ANRF’s Scientific Advisory Board.

2019-20 ANRF Partner Institutions

Creating Meaningful Collaborations


As you can see this year’s awardees stretch across the country and specialize in a range of arthritis and related autoimmune diseases, from osteoarthritis to rheumatoid arthritis and from juvenile arthritis to scleroderma. The full list of our 2019-20 ANRF Scholars and their projects can be seen at CureArthritis.org/arthritis-research-2019

A Special Thank You To Our Research Partners

 

Foundation Partners

Research Partners

We need your support to continue funding this critical research. Please make a donation to today and help the estimated 54 million Americans, including 300,000 children suffering with arthritis.

ANRF
Article Author
Arthritis National Research Foundation
arthritisresearch@curearthritis.org

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

No Comments

Post A Comment